BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16094092)

  • 1. Re: Pediatric ceftriaxone nephrolithiasis.
    Avci Z; Karadag A; Odemis E; Catal F
    J Urol; 2005 Sep; 174(3):1153. PubMed ID: 16094092
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrolithiasis in a child with acute pyelonephritis. Ceftriaxone-induced nephrolithiasis and biliary pseudolithiasis.
    Tasic V; Sofijanova A; Avramoski V
    Pediatr Nephrol; 2005 Oct; 20(10):1510-1, 1512-3. PubMed ID: 16082553
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
    Prince JS; Senac MO
    Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children.
    Avci Z; Koktener A; Uras N; Catal F; Karadag A; Tekin O; Degirmencioglu H; Baskin E
    Arch Dis Child; 2004 Nov; 89(11):1069-72. PubMed ID: 15499067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric ceftriaxone nephrolithiasis.
    Gargollo PC; Barnewolt CE; Diamond DA
    J Urol; 2005 Feb; 173(2):577-8. PubMed ID: 15643261
    [No Abstract]   [Full Text] [Related]  

  • 6. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
    Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
    Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis.
    de Moor RA; Egberts AC; Schröder CH
    Eur J Pediatr; 1999 Dec; 158(12):975-7. PubMed ID: 10592073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute urine retention induced by ceftriaxone.
    Akl KF; Masri AT; Hjazeen MM
    Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1226-8. PubMed ID: 22089789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of nephrolithiasis occurrence in children receiving cefotriaxone.
    Youssef DM; Sherief LM; Sherbiny HS; ElAttar MY; Sheikh AR; Fawzy FM; Adham T
    Nephrology (Carlton); 2016 May; 21(5):432-7. PubMed ID: 26369807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection.
    Roncon-Albuquerque R; Pires I; Martins R; Real R; Sousa G; von Hafe P
    Neth J Med; 2009 Feb; 67(2):72-5. PubMed ID: 19299850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone-associated Pseudolithiasis in the Gallbladder and Bile Duct of an Elderly Patient.
    Yamabe A; Irisawa A; Wakabayashi H; Tsunoda T; Tominaga K
    Intern Med; 2020 Nov; 59(21):2725-2728. PubMed ID: 32669492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serious side effects of frequently used antibiotics in childhood: biliary sludge or stones induced by ceftriaxone and thrombocytopenia induced by co-trimoxazole].
    Voeten M; Landstra AM; Maseland MH; van Setten PA
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1299-303. PubMed ID: 17624162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
    Mohkam M; Karimi A; Gharib A; Daneshmand H; Khatami A; Ghojevand N; Sharifian M
    Pediatr Nephrol; 2007 May; 22(5):690-4. PubMed ID: 17226043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone induced hemolysis complicated by acute renal failure.
    Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
    Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftriaxone-associated nephrolithiasis.
    Cochat P; Cochat N; Jouvenet M; Floret D; Wright C; Martin X; Vallon JJ; David L
    Nephrol Dial Transplant; 1990; 5(11):974-6. PubMed ID: 2127836
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitamin K deficiency because of ceftriaxone usage and prolonged diarrhoea.
    Yılmaz S; Tavil B; Sarı S; Cinaz P
    J Paediatr Child Health; 2011 May; 47(5):314-5. PubMed ID: 21599785
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
    Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and elemental composition of Ceftriaxone induced pediatric nephrolithiasis.
    Du Y; Kang M; Mena J; Stoller ML; Ho SP; Li J
    Urolithiasis; 2021 Aug; 49(4):309-320. PubMed ID: 33587147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.